Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapNeutral

REG - AIM - AIM Notice - 21/03/2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220321:nRSU3298Fa&default-theme=true

RNS Number : 3298F  AIM  21 March 2022

NOTICE

 

21/03/2022 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ALPHA FX GROUP PLC
 1,123,946  ORDINARY SHARES OF 0.2P EACH FULLY PAID  (BF1TM59)(GB00BF1TM596)

 

 CENTRALNIC GROUP PLC
 2,500,000  ORDINARY SHARES OF 0.1P EACH FULLY PAID  (BCCW4X8)(GB00BCCW4X83)

 

 CORCEL PLC
 12,793,333  ORDINARY SHARES OF 0.01P EACH, FULLY PAID  (BKM6986)(GB00BKM69866)

 

 GRESHAM HOUSE PLC
 73,177  ORDINARY SHARES OF 25P EACH, FULLY PAID  (0388728)(GB0003887287)

 

 MYCELX TECHNOLOGIES CORPORATION
 3,384,273  COMMON SHARES OF USD0.025 EACH, FULLY PAID (REGULATION S) (DI)  (BPNZX74)(USU624551235)

 

 REDCENTRIC PLC
 237,500  ORDINARY SHARES OF 0.1P EACH  (B7TW1V3)(GB00B7TW1V39)

 

 SENSYNE HEALTH PLC
 1,428,571  ORDINARY SHARES OF 10P EACH, FULLY PAID  (BYV3J75)(GB00BYV3J755)

 

 SOMERO ENTERPRISE INC.
 40,467  COMMON SHARES OF USD0.001 EACH, FULLY PAID (DI)  (B1GCQ97)(USU834501038)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDXLDBDGDI

Recent news on Mycelx Technologies

See all news